Literature DB >> 22772885

[Molecular physical medicine].

U Lange1.   

Abstract

A multimodal treatment of inflammatory rheumatic diseases without physical medicine is almost always incomplete. The mechanisms underlying the positive effects of physical medicine are only partially understood. Modern molecular medicine offers new insights into pivotal mechanisms and mediators of the inflammatory process and into interactions between cells of the immune system and the bone. Investigating the potential influences of different methods of physical medicine on the central regulatory processes of inflammatory rheumatic diseases is of great interest, highly fascinating and opens up new avenues of research for the future. This article focuses on the first novel results of molecular physical medicine in rheumatic and degenerative diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22772885     DOI: 10.1007/s00393-011-0866-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  15 in total

Review 1.  [Physical medicine in rheumatology and orthopedics].

Authors:  U Lange
Journal:  Versicherungsmedizin       Date:  2009-03-01

2.  Different effects of local cryogel and cold air physical therapy in wrist rheumatoid arthritis visualised by power Doppler ultrasound.

Authors:  K Albrecht; C Albert; U Lange; U Müller-Ladner; J Strunk
Journal:  Ann Rheum Dis       Date:  2009-07       Impact factor: 19.103

3.  Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomised single blinded controlled trial.

Authors:  H E Hirvonen; M K Mikkelsson; H Kautiainen; T H Pohjolainen; M Leirisalo-Repo
Journal:  Clin Exp Rheumatol       Date:  2006 May-Jun       Impact factor: 4.473

4.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 7.  Ice freezes pain? A review of the clinical effectiveness of analgesic cold therapy.

Authors:  E Ernst; V Fialka
Journal:  J Pain Symptom Manage       Date:  1994-01       Impact factor: 3.612

Review 8.  CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.

Authors:  Damaris Vega; Naim M Maalouf; Khashayar Sakhaee
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

9.  [Serial whole-body cryotherapy in the criostream for inflammatory rheumatic diseases. A pilot study].

Authors:  Uwe Lange; Christine Uhlemann; Ulf Müller-Ladner
Journal:  Med Klin (Munich)       Date:  2008-06-15

Review 10.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

View more
  3 in total

1.  The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.

Authors:  Uwe Lange; Gabriel Dischereit; Ingo Tarner; Klaus Frommer; Elena Neumann; Ulf Müller-Ladner; Bernhard Kürten
Journal:  Clin Rheumatol       Date:  2016-04-06       Impact factor: 2.980

2.  [Molecular effects of physical therapy. What's new?].

Authors:  U Lange; I H Tarner; G Dischereit; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

Review 3.  [Molecular physical medicine in rheumatic disease patterns].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.